Immune profile test for women with chronic pelvic pain and endometriosis
Official title: Identify a Specific Immune Profile in Patients With Chronic Pelvic Pain Resistant to First-line Treatments by Measuring Th1, Th2, Th17, and Treg Cytokines Produced After Non-specific Functional Cell Stimulation - ImmunoCPP
Run by Centre Hospitalier Universitaire de Nice · NCT07429773 · Data updated 2026-11-12
This study tests a functional immune test to see if immune profiles differ in women with chronic pelvic pain and endometriosis who aren’t responding to first-line treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | Centre Hospitalier Universitaire de Nice Academic / other |
| Locations | 1 site (Nice, Alpes-Maritimes) |
| Status | Recruiting |
| Started | April 14, 2026 |
| Main results expected | April 2028 |
| Study ends | April 2028 |
| Registry record updated | July 27, 2026 |
| Trial ID | NCT07429773 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18–40 with chronic pelvic pain and suspected or confirmed endometriosis who are on continuous hormone treatment and have recent imaging within 12 months.
✕Probably not a fit
Patients with autoimmune disease, recent cancer treatment, pregnancy, breastfeeding, or infectious illness may not benefit from this immune profiling test.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study uses an immune profiling approach by measuring Th1, Th2, Th17, and Treg cytokines after non-specific functional cell stimulation to identify immune imbalances in women with chronic pelvic pain and endometriosis. It is conducted in a real-world setting among patients aged 18 to 40 who are on long-term hormone therapy and have recent imaging results. The trial is interventional and focuses on a blood-based immune test to characterize the immune response rather than a traditional drug or device therapy. Primary results will describe whether this functional immune test can reliably characterize immune profiles associated with CPP and endometriosis in this population.
Why it matters
Potential benefit: If successful, the test could help tailor treatments based on a patient’s immune profile and improve management of chronic pelvic pain.
How similar studies have gone: Prior immune-function tests have shown promise in infertility contexts; applicability to CPP/endometriosis is exploratory and not yet validated in this specific setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged between 18 and 40; 2. Under continuous hormone treatment for at least 6 months; 3. Imaging less than 12 months old: either normal or showing endometriosis and/or adenomyosis lesions, excluding any other abnormalities that could explain the PCOS; 4. Affiliation with the French Social Security system; 5. Signature of informed consent. Exclusion Criteria: 1. Pregnant or breastfeeding women; 2. Autoimmune disease; 3. History of cancer within the last 5 years or currently undergoing treatment; 4. Current infectious syndrome; 5. Person under guardianship or conservatorship.
Where it's running
-
CHU Nice - Hôpital de l'Archet 2
Nice, Alpes-Maritimes, France Recruiting
Study contacts
- Study coordinator: Pierre-Alexis GAUCI, MD
- Email: gauci.pa@chu-nice.fr
- Phone: 04 92 03 61 90
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing different techniques to treat endometriosis
This study is testing different methods to treat endometriosis, like laser and heat techniques, to see which one works best for relieving pain in women who are already having surgery for the condition.
-
Tele-rehabilitation for chronic pelvic pain in endometriosis
This study is testing a tele-rehabilitation program to see if it can help women with endometriosis and chronic pelvic pain feel better through online sessions that include pain education and exercises.
-
Esketamine for treating chronic pain from endometriosis
This study is testing whether esketamine can help women with endometriosis feel less chronic pelvic pain compared to a placebo.
-
Postoperative Pain Trajectories After Endometriosis Surgery
This study tests how pain changes after endometriosis surgery and whether perioperative pain testing can predict who will have ongoing pain.
-
Imaging endometriosis with a special PET tracer in adult women
This study tests whether a PET/CT scan using [18F]AlF-FAPI-74 can help detect endometriosis lesions in women who are planning laparoscopy.
-
Fiber supplement for digestive symptoms in endometriosis
A fiber-based supplement is being tested to see if it is safe and helps with gut and vaginal microbiomes and digestive symptoms in women with endometriosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.